相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Association of gene expression involving innate immunity and genetic variation in interleukin 28B with antiviral response
Yasuhiro Asahina et al.
HEPATOLOGY (2012)
Twice-weekly pegylated interferon-α-2a and ribavirin results in superior viral kinetics in HIV/hepatitis C virus co-infected patients compared to standard therapy
Alison A. Murphy et al.
AIDS (2011)
Evolving epidemiology of hepatitis C virus
D. Lavanchy
CLINICAL MICROBIOLOGY AND INFECTION (2011)
Viral hepatitis and HIV co-infection
Vincent Soriano et al.
ANTIVIRAL RESEARCH (2010)
Albinterferon Alfa-2b Was Not Inferior to Pegylated Interferon-α in a Randomized Trial of Patients With Chronic Hepatitis C Virus Genotype 2 or 3
David R. Nelson et al.
GASTROENTEROLOGY (2010)
Albinterferon Alfa-2b Was Not Inferior to Pegylated Interferon-α in a Randomized Trial of Patients With Chronic Hepatitis C Virus Genotype 1
Stefan Zeuzem et al.
GASTROENTEROLOGY (2010)
HIV/Hepatitis C Virus-Coinfected Virologic Responders to Pegylated Interferon and Ribavirin Therapy More Frequently Incur Interferon-Related Adverse Events Than Nonresponders Do
Anu Osinusi et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2010)
Therapeutic response to peg-IFN-alpha-2b and ribavirin in HIV/HCV co-infected African-American and Caucasian patients as a function of HCV viral kinetics and interferon pharmacodynamics
Lynn Rozenberg et al.
AIDS (2009)
Safety and Antiviral Activity of Albinterferon Alfa-2b in Prior Interferon Nonresponders With Chronic Hepatitis C
David R. Nelson et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2009)
Modeling HCV kinetics under therapy using PK and PD information
Emi Shudo et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2009)
Human Immunodeficiency Virus and Hepatitis C Infections Induce Distinct Immunologic Imprints in Peripheral Mononuclear Cells
Shyam Kottilil et al.
HEPATOLOGY (2009)
Hepatitis C Viral Kinetics During Treatment With Peg IFN-alpha-2b in HIV/HCV Coinfected Patients as a Function of Baseline CD4+ T-Cell Counts
Neumann U. Avidan et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2009)
Safety and antiviral activity of albinterferon alfa-2b dosed every four weeks in genotype 2/3 chronic hepatitis C patients
Vincent G. Bain et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
Phenotype and Function of Human T Lymphocyte Subsets: Consensus and Issues
Victor Appay et al.
CYTOMETRY PART A (2008)
Immune activation and inflammation in HIV-I infection: causes and consequences
V. Appay et al.
JOURNAL OF PATHOLOGY (2008)
Albinterferon α-2b:: a genetic fusion protein for the treatment of chronic hepatitis C
G. Mani Subramanian et al.
NATURE BIOTECHNOLOGY (2007)
Peginterferon alfa-2b and weight-based or flat-dose ribavirin in chronic hepatitis C patients: A randomized trial
Ira M. Jacobson et al.
HEPATOLOGY (2007)
HCV kinetics, quasispecies, and clearance in treated HCV-infected and HCV/HIV-1-coinfected patients with hemophilia
Norah J. Shire et al.
HEPATOLOGY (2006)
Predictors for hematopoietic growth factors use in HIV/HCV-coinfected patients treated with peginterferon alfa 2b and ribavirin
Alice K. Pau et al.
AIDS PATIENT CARE AND STDS (2006)
Pegylated interferon α-2b plus ribavirin for the treatment of chronic hepatitis C in HIV-coinfected patients
Esther Voigt et al.
JOURNAL OF INFECTION (2006)
Gene expression profiles in hepatitis C virus (HCV) and HIV coinfection: Class prediction analyses before treatment predict the outcome of anti-HCV therapy among HIV-coinfected persons
RA Lempicki et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Hepatitis C virus (HCV) relapses after anti-HCV therapy are more frequent in HIV-infected patients
V Soriano et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2004)
Care of patients with hepatitis C and HIV co-infection
V Soriano et al.
AIDS (2004)
Serious ophthalmic pathology compromising vision in HCV/HIV co-infected patients treated with peginterferon alpha-2b and ribavirin
C Farel et al.
AIDS (2004)
Peginterferon alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons
RT Chung et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients
FJ Torriani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Hematologic disorders associated with hepatitis C virus infection and their management
DT Dieterich et al.
CLINICAL INFECTIOUS DISEASES (2003)
Deleterious effect of HIV-1 plasma viremia on B cell costimulatory function
A Malaspina et al.
JOURNAL OF IMMUNOLOGY (2003)
Elevated serum levels of soluble immune activation markers are associated with increased risk for death in HAART-naive HIV-1-infected patients
NV Sipsas et al.
AIDS PATIENT CARE AND STDS (2003)
Hepatitis C virus prevalence among patients infected with human immunodeficiency virus: A cross-sectional analysis of the US adult AIDS clinical trials group
KE Sherman et al.
CLINICAL INFECTIOUS DISEASES (2002)
分享论文
